Cacti Asset Management Has Increased By $7.09 Million Its Blackstone Group LP (BX) Holding; Immune Design (IMDZ) Sellers Increased By 18.26% Their Shorts

Immune Design Corporation (NASDAQ:IMDZ) had an increase of 18.26% in short interest. IMDZ’s SI was 1.59M shares in February as released by FINRA. Its up 18.26% from 1.35M shares previously. With 604,700 avg volume, 3 days are for Immune Design Corporation (NASDAQ:IMDZ)’s short sellers to cover IMDZ’s short positions. It closed at $3.25 lastly. It is down 40.11% since February 14, 2017 and is downtrending. It has underperformed by 56.81% the S&P500.

Cacti Asset Management Llc increased Blackstone Group LP (BX) stake by 21.07% reported in 2017Q3 SEC filing. Cacti Asset Management Llc acquired 221,558 shares as Blackstone Group LP (BX)’s stock declined 1.16%. The Cacti Asset Management Llc holds 1.27M shares with $41.92M value, up from 1.05M last quarter. Blackstone Group LP now has $39.83B valuation. The stock increased 0.81% or $0.27 during the last trading session, reaching $33.55. About 12.71M shares traded or 159.01% up from the average. The Blackstone Group L.P. (NYSE:BX) has risen 20.49% since February 14, 2017 and is uptrending. It has outperformed by 3.79% the S&P500.

Since October 27, 2017, it had 2 insider purchases, and 5 insider sales for $21.92 million activity. 675 shares valued at $2,816 were sold by Yurasov Sergey on Thursday, January 4. Shares for $10.99 million were bought by Svennilson Peter on Friday, October 27. Shares for $8,282 were sold by Gombotz Wayne. On Thursday, January 4 the insider ter Meulen Jan Henrik sold $8,282. $33,247 worth of stock was sold by Paya Carlos V on Thursday, January 4. On Thursday, January 4 Brady Stephen R sold $13,885 worth of Immune Design Corp. (NASDAQ:IMDZ) or 3,328 shares. COLUMN GROUP L P bought $10.99M worth of Immune Design Corp. (NASDAQ:IMDZ) on Friday, October 27.

Among 5 analysts covering Immune Design (NASDAQ:IMDZ), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Immune Design has $40 highest and $10 lowest target. $22’s average target is 576.92% above currents $3.25 stock price. Immune Design had 10 analyst reports since August 18, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of IMDZ in report on Tuesday, June 6 with “Buy” rating. The rating was maintained by Jefferies with “Buy” on Monday, September 4. Jefferies initiated the stock with “Buy” rating in Wednesday, September 9 report. The rating was initiated by Leerink Swann on Tuesday, August 18 with “Outperform”. The rating was maintained by Jefferies on Wednesday, August 10 with “Buy”. The rating was maintained by Jefferies with “Buy” on Thursday, October 5. The firm has “Market Perform” rating given on Wednesday, October 18 by Wells Fargo. Jefferies maintained Immune Design Corp. (NASDAQ:IMDZ) rating on Monday, June 26. Jefferies has “Buy” rating and $1800 target.

Investors sentiment decreased to 1.27 in Q3 2017. Its down 1.17, from 2.44 in 2017Q2. It turned negative, as 5 investors sold Immune Design Corp. shares while 21 reduced holdings. 13 funds opened positions while 20 raised stakes. 11.88 million shares or 8.39% more from 10.96 million shares in 2017Q2 were reported. Bancorporation Of Mellon Corporation owns 0% invested in Immune Design Corp. (NASDAQ:IMDZ) for 72,609 shares. Zacks owns 0.03% invested in Immune Design Corp. (NASDAQ:IMDZ) for 117,545 shares. 1.41 million are held by Proquest Iv Limited Com. Bridgeway reported 116,800 shares or 0.01% of all its holdings. 12,100 were reported by Alliancebernstein Lp. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in Immune Design Corp. (NASDAQ:IMDZ) for 1,477 shares. Meeder Asset Inc invested in 0% or 159 shares. Trexquant Invest Limited Partnership has 0.04% invested in Immune Design Corp. (NASDAQ:IMDZ). Dimensional Fund Advisors Ltd Partnership, a Texas-based fund reported 18,896 shares. Doheny Asset Mngmt Ca accumulated 611,550 shares. Moreover, Deutsche Commercial Bank Ag has 0% invested in Immune Design Corp. (NASDAQ:IMDZ). Focused Wealth Mngmt accumulated 13,065 shares. Switzerland-based Credit Suisse Ag has invested 0% in Immune Design Corp. (NASDAQ:IMDZ). Moreover, Franklin Res Inc has 0% invested in Immune Design Corp. (NASDAQ:IMDZ) for 781,753 shares. Tower Cap Limited Liability Co (Trc) has 2,225 shares for 0% of their portfolio.

Since December 13, 2017, it had 0 insider buys, and 1 sale for $632,896 activity. 20,000 shares were sold by Finley John G, worth $632,896 on Wednesday, December 13.